Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 553-554
DOI: 10.1111/apt.70765 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 01.06.2026. Verfasst von Hsiang-Ting Keng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.
- College of Medicine, Chang Gung University, Taipei, Taiwan.
ORCID-Profile: Yen-Chun Liu, Wen-Juei Jeng
Zitieren
APA
Keng, H. T., Liu, Y. C., & Jeng, W. J. (2026). Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance. Alimentary Pharmacology & Therapeutics, 64(4), 553-554. https://doi.org/10.1111/apt.70765
Vancouver
Keng HT, Liu YC, Jeng WJ. Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance. Alimentary Pharmacology & Therapeutics. 2026;64(4):553-554. doi:10.1111/apt.70765
BibTeX
@article{Keng2026,
author = {Keng, Hsiang-Ting and Liu, Yen-Chun and Jeng, Wen-Juei},
title = {Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {4},
pages = {553--554},
doi = {10.1111/apt.70765}
}
EUVIMED